How do my hormones affect my cholesterol?

Despite decades of research on prevention, detection, and management, coronary heart disease is still a number one cause of mortality and morbidity in the developed world for both men and women. A major risk factor for both myocardial infarction and atherosclerosis is hypercholesterolemia.

Anti-aging medicine concepts and interventions were shown to be highly relevant with regards to hormone replacement therapy in a small clinical study by Dzugan et al. in 2002. The theory presented was the belief that high cholesterol levels were a consequence of low production of steroid hormones, i.e., estrogen, progesterone and testosterone. After youthful levels of these hormones were restored, total cholesterol dropped by 23.5 percent and normalized completely in 61.6 percent of patients. It is also important to note that individual dosing with bio-identical hormones were used. In this study all patients reported an increase in quality of life. So, it seems bio-identical hormone replacement therapy has been shown to be an effective approach in the control of hypercholesterolemia.

Treatment for high cholesterol (dyslipidemia) should start with optimal nutrition, diet, and ideal body weight, along with an aerobic and resistance exercise program. If appropriate for a low to moderate risk person, nutritional supplements are utilized. Some nutraceuticals that have shown to have the best clinical data for lowering lipid levels are tocotrienols, pantethine, omega-3 fatty acids, niacin, red yeast rice, probiotics, curcumin, green tea extract and plant sterols. However, those with high or very high risk will likely need pharmacological agents used in conjunction with diet, exercise, weight loss, and nutraceuticals, along with hormone corrective therapy.

Bio-identical hormone replacement used to correct estrogen, progesterone and testosterone to optimal levels helps to keep the heart and body healthy. Estrogen increases HDL (good) cholesterol by 10 to 15 percent. It also decreases lipoprotein A, which is a major risk factor for heart disease. Estrogen also lowers homocysteine, as well as acting as a natural calcium channel blocker to keep arteries open, reducing the risk of heart disease by as much as 40-50 percent.

Progesterone without adequate estrogen not only increases weight gain, it also increases LDL cholesterol, decreases HDL cholesterol and increases triglycerides. Inadequate levels of testosterone also results in low HDL cholesterol.

Remember, your hormones are like a web; they are a symphony, working together for total body optimal functioning. If there is a deficiency in any one area, the actions of other areas will be affected. Replacement of your hormones should be individualized and monitored for adjustments as your body fluctuates in response to life's stresses.

For more information, contact Jan Nelson at Balanced Wellness Medical Clinic, (509) 919-4575, jnelson@balancedwellnessmed.com, http://www.balancedwellnessmed.com.

See the rest here:
How do my hormones affect my cholesterol?

Nanoparticles could help guide surgery on cancer cells

Scientists from Oregon State University in the US have developed a means to selectively introduce compounds into cancer cells so that they can be identified and malignant tissues removed in combination with phototherapy, and also killing remaining cancer cells once a tumor has been removed, preventing recurrence. Based on successful laboratory trials, this mix of surgery and non-toxic phototherapy has great potential for improving on existing chemotherapies and radiotherapies.

Although for many cancers surgery is the first choice treatment, it is not easy to remove most of the tumors, and residual cancer cells can eventually lead to relapse. The team were therefore exploring novel nanotechnology-based platforms to treat different cancers using intraoperative guidance with a real-time near infrared (NIR) fluorescence signal. As reported in the journal Nanoscale [Taratula et al. Nanoscale (2015) DOI: 10.1039/C4NR06050D], they devised a system for greater accuracy in the surgical removal of solid tumors and eradicating remaining cancer cells using the compound naphthalocyanine.

This derivative of phthalocyanine has unusual properties when exposed to near-infrared light, such as making cells glow thus helping to guide surgeons to specific cells and heating the cell to kill it off through mild heating and the development of reactive oxygen species. By adjusting the intensity of the light, the action of the compound can be controlled and optimized to kill only the tumor and cancer cells, and nothing else. It is hoped that this double attack from 'glowing' nanotechnology based on a single-agent-based nanomedicine platform capable of both NIR fluorescence imaging and combinatorial phototherapy could significantly improve the success of cancer surgeries.

However, while naphthalocyanine is commercially available, its potential clinical application is limited by low water solubility and aggregation, which reduces its ability to make cells glow and generate reactive oxygen species, as well as preventing it from finding its way through the circulatory system to reach specific cells. They overcame these obstacles through the use of a special water-soluble nanoparticle polymer called a dendrimer, which allows the compound to be concealed within a molecule that attaches to cancer cells.

Although the process has demonstrated in laboratory mice, the team will look to make improvements before testing on larger animals with malignant tumors. They also hope to explore the optimization of this nanomedicine platform by focusing on the performance of image-guided cancer surgery and intraoperative phototherapy and employing it with an imaging system specifically designed for real-time NIR imaging.

Read more:
Nanoparticles could help guide surgery on cancer cells

Logical Operations Announces New Cybersecurity Training Course and Certification, CyberSec First Responder: Threat …

Rochester, N.Y. (PRWEB) January 13, 2015

Logical Operations, the worlds leading provider of information technology instructor-led courseware, today announces the development of a new cybersecurity training course, CyberSec First Responder: Threat Detection and Response, and corresponding certification, Certified CyberSec First Responder, to help organizations combat cybersecurity threats.

2014 saw an exceptional number of IT security breaches, which are part of an overall trend in increasingly destructive hacking incidents. These hacking incidents further highlight the enormous demand for qualified security professionals who can protect their organizations networks and prevent significant losses. Logical Operations has leveraged its knowledge and years of experience in the security training industry to develop the new CyberSec First Responder: Threat Detection and Response training curriculum and certification program. This five-day instructor-led training curriculum, available in March 2015, is designed for information assurance professionals who perform job functions related to the development, operation, management, and enforcement of security capabilities for systems and networks. The CyberSec First Responder: Threat Detection and Response course will prepare security professionals to become the first line of response against cyber attacks by teaching students to analyze threats, design secure computing and network environments, proactively defend networks, and respond/investigate cybersecurity incidents. Following the release of the curriculum in March 2015, the course will be available on Logical Operations virtual training schedule, Instructor Assist.

Were extremely proud to announce the addition of CyberSec First Responder: Threat and Response to our IT Security training portfolio, said Bill Rosenthal, CEO, Logical Operations. Here at Logical Operations, we know that people are the key to protecting an organizations network; even with the best hardware and software solutions, an organization wont be fully protected without properly trained professionals. Our expertise in the IT security training field has allowed us to create a training course and certification program that uniquely meets the training needs of todays security professionals and organizations everywhere.

"These are challenging times for organizations of all kinds. Being part of the global business ecosystem represents inherent risks that become unacceptable at times. The stakes are higher: threats are more pervasive and stealth, as demonstrated by the latest Advanced Persistent Threats in the wild, said Carlos Moros, Senior Security Consultant and industry expert. The assets we are trying to protect are more relevant than ever, from personal data to infrastructure and national security targets. The attack surface is now expanded exponentially, with mobility, device agnosticism, and cloud services leading the way. Hiring qualified professionals sometimes feels like an adventure, as the required technical, functional, and organizational skills pile up. I am convinced that organizations will find the CyberSec First Responder certification invaluable in baselining their requirements and finding those unique individuals who can do the job effectively."

About Logical Operations Logical Operations helps organizations and individuals maximize training with an adaptable expert-facilitated learning experience. Its more than 4,600 titles are available through flexible delivery platforms that are designed for any learning environment. For more information, connect with Logical Operations at http://logicaloperations.com and on Twitter @logicalops.

View post:
Logical Operations Announces New Cybersecurity Training Course and Certification, CyberSec First Responder: Threat ...

Angelina Jolie has flown to Italy to meet Pope Francis.

The duo's head of security is said to have arrived in the city to begin preparations for their arrival a few days ago.

A source close to the couple, who consider themselves non-religious, told Us Weekly magazine that the 39-year-old beauty and the 51-year-old actor both "admire the Pope" and "like the Pope's message."

Pope Francis has been praised for being more tolerant than his predecessors. When asked about views on homosexuality last year, he said: "If someone is gay and he searches for the Lord and has goodwill, who am I to judge?"

'Fury' star Brad was raised a Baptist, but previously admitted he didn't "have a great relationship with religion."

He said: "I oscillate between agnosticism and atheism."

But Angelina recently revealed she is very spiritual.

She said: "I don't know if there's a name for that - religion or faith - just that there's something greater than all of us, and it's uniting and beautiful."

The rest is here:
Angelina Jolie has flown to Italy to meet Pope Francis.

HOW TO SURVIVE FIRST YEAR OF MEDICAL SCHOOL | #3 Medical School Series – Video


HOW TO SURVIVE FIRST YEAR OF MEDICAL SCHOOL | #3 Medical School Series
In this episode of the medical school series I am talking about how to survive first year of medical school. Hope you enjoy it :). x For questions or enquiries please contact us at: *** davidanda...

By: AdannaDavid

Read the rest here:
HOW TO SURVIVE FIRST YEAR OF MEDICAL SCHOOL | #3 Medical School Series - Video

Lakers Jeremy Lin Talks Nick Young’s Shooting Slump, Bench Chemistry – Video


Lakers Jeremy Lin Talks Nick Young #39;s Shooting Slump, Bench Chemistry
After the Lakers loss to the Portland Trailblazers, Jeremy Lin says the second unit tried to get Nick Young out of his shooting slump, plus talks Carlos Boozer and the chemistry of the second...

By: Lakers Nation

Go here to see the original:
Lakers Jeremy Lin Talks Nick Young's Shooting Slump, Bench Chemistry - Video

Is stem cell therapy less effective in older patients with chronic diseases?

IMAGE:BioResearch Open Access is a bimonthly peer-reviewed open access journal led by Editor-in-Chief Robert Lanza, MD, Chief Scientific Officer, Advanced Cell Technology, Inc. and Editor Jane Taylor, PhD. The Journal... view more

Credit: Mary Ann Liebert, Inc., publishers

New Rochelle, NY, January 12, 2014--A promising new therapeutic approach to treat a variety of diseases involves taking a patient's own cells, turning them into stem cells, and then deriving targeted cell types such as muscle or nerve cells to return to the patient to repair damaged tissues and organs. But the clinical effectiveness of these stem cells has only been modest, which may be due to the advanced age of the patients or the effects of chronic diseases such as diabetes and cardiovascular disease, according to a probing Review article published in BioResearch Open Access, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers . The article is available on the BioResearch Open Access website.

Anastasia Yu. Efimenko, TN Kochegura, ZA Akopyan, and YV Parfyonova, Moscow State University (Russia), analyze how aging and chronic diseases might affect the regenerative potential of autologous stem cells and explain the differences between the promising results reported in preclinical studies using stem cells derived from healthy young donors and the more modest success of clinical studies in aged patients. The authors propose strategies to test for and enhance to regenerative properties and therapeutic potential of stem cells in the article "Autologous Stem Cell Therapy: How Aging and Chronic Diseases Affect Stem and Progenitor Cells".

"This review discusses a very important issue in regenerative medicine, how aging and chronic pathologies such as cardiovascular diseases and metabolic disorders affect adult stem/progenitor cells," says BioResearch Open Access Editor Jane Taylor, PhD, MRC Centre for Regenerative Medicine, University of Edinburgh, Scotland. "Future therapies are discussed by the authors in terms of overcoming or correcting the limitations of these cells in order to enhance their therapeutic potential."

###

About the Journal

BioResearch Open Access is a bimonthly peer-reviewed open access journal led by Editor-in-Chief Robert Lanza, MD, Chief Scientific Officer, Advanced Cell Technology, Inc. and Editor Jane Taylor, PhD. The Journal provides a new rapid-publication forum for a broad range of scientific topics including molecular and cellular biology, tissue engineering and biomaterials, bioengineering, regenerative medicine, stem cells, gene therapy, systems biology, genetics, biochemistry, virology, microbiology, and neuroscience. All articles are published within 4 weeks of acceptance and are fully open access and posted on PubMed Central. All journal content is available on the BioResearch Open Access website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many areas of science and biomedical research, including DNA and Cell Biology, Tissue Engineering, Stem Cells and Development, Human Gene Therapy, HGT Methods, and HGT Clinical Development, and AIDS Research and Human Retroviruses. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

See the article here:
Is stem cell therapy less effective in older patients with chronic diseases?

Neurology session at the 2014 TSC Family Conference in Auckland New Zealand – Video


Neurology session at the 2014 TSC Family Conference in Auckland New Zealand
Dr Melinda Nolan and Dr Claire Spooner explain how TSC affects the brain and the available management and treatment options. Includes questions from the audi...

By: AuTuberousSclerosis

The rest is here:
Neurology session at the 2014 TSC Family Conference in Auckland New Zealand - Video